WHO estimates up to $54 in returns per dollar spent on TB
A four-country model says finding tuberculosis and treating infection early pays off in health and money; it is a projection, not an observed result.
The World Health Organization (WHO) published on Oct. 12, 2026 the second edition of a 17-page technical document titled "Funding a tuberculosis-free future" and subtitled "an investment case". It argues that paying for tuberculosis screening and for preventive treatment of the infection pays off in both health and economic terms. According to the agency, the return can reach $54 for every dollar invested.
The figure comes from a modeling study of four countries: Brazil, Georgia, Kenya and South Africa. It is not a clinical trial or a follow-up of patients but a projection that depends on the model's assumptions, and 54 is the maximum, not an average. The WHO page lists neither the total cost nor how many lives would be saved. The WHO says the results show "significant health and economic benefits" in all four cases and that the countries can serve as examples for others with a similar epidemiology.
The approach rests on telling infection apart from disease. The Centers for Disease Control and Prevention (CDC) of the United States explain that in inactive tuberculosis the bacteria stay in the body without symptoms and without spreading, but can progress to active disease if left untreated. The WHO says in its fact sheet that preventive treatment stops that step.
The disease burden
The same fact sheet, updated on March 24, 2026, estimates that in 2024 some 10.7 million people fell ill with tuberculosis and 1.23 million died, about 150 000 of them with HIV. Among those who fell ill were 5.8 million men, 3.7 million women and 1.2 million children.
As symptoms of active disease, the WHO and the CDC list a cough that lingers, sometimes with blood, along with chest pain, weakness, weight loss, fever and night sweats. Some people with active disease have no symptoms and can still spread it.
The CDC aim their testing recommendations at people at higher risk: those who live or work in hospitals, shelters or prisons, who recently had contact with someone with active tuberculosis, or whose defenses are low because of conditions such as diabetes, cancer or HIV. There is a blood test and a skin test, and if a test is positive, a chest X-ray and a sputum analysis are added to tell infection from disease.
The document is not a clinical guideline and does not change who should be tested: it argues, with figures from four countries, that investing in detection and prevention pays for itself. It applies as prevention information to the general population, while the tests the CDC describe focus on higher-risk groups. Still pending is the full text of the model, with its range of results and assumptions, which the WHO page does not summarize, and no recent official figures for Mexico were consulted.
